838 related articles for article (PubMed ID: 2957433)
1. Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium.
van Dissel JT; Stikkelbroeck JJ; Michel BC; van den Barselaar MT; Leijh PC; van Furth R
J Immunol; 1987 Sep; 139(5):1673-8. PubMed ID: 2957433
[TBL] [Abstract][Full Text] [Related]
2. Divergent changes in antimicrobial activity after immunologic activation of mouse peritoneal macrophages.
van Dissel JT; Stikkelbroeck JJ; van den Barselaar MT; Sluiter W; Leijh PC; van Furth R
J Immunol; 1987 Sep; 139(5):1665-72. PubMed ID: 2957432
[TBL] [Abstract][Full Text] [Related]
3. Intravenous injection of interferon-gamma inhibits the proliferation of Listeria monocytogenes in the liver but not in the spleen and peritoneal cavity.
Langermans JA; van der Hulst ME; Nibbering PH; van der Meide PH; van Furth R
Immunology; 1992 Nov; 77(3):354-61. PubMed ID: 1478682
[TBL] [Abstract][Full Text] [Related]
4. Salmonella-typhimurium-specific difference in rate of intracellular killing by resident peritoneal macrophages from salmonella-resistant CBA and salmonella-susceptible C57BL/10 mice.
van Dissel JT; Stikkelbroeck JJ; Michel BC; Leijh PC; van Furth R
J Immunol; 1987 Jun; 138(12):4428-34. PubMed ID: 3295047
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma.
Black CM; Catterall JR; Remington JS
J Immunol; 1987 Jan; 138(2):491-5. PubMed ID: 3098846
[TBL] [Abstract][Full Text] [Related]
6. Differences in initial rate of intracellular killing of Salmonella typhimurium by granulocytes of Salmonella-susceptible C57BL/10 mice and Salmonella-resistant CBA mice.
van Dissel JT; Stikkelbroeck JJ; Sluiter W; Leijh PC; van Furth R
J Immunol; 1986 Feb; 136(3):1074-80. PubMed ID: 3079795
[TBL] [Abstract][Full Text] [Related]
7. Activation of mouse peritoneal macrophages during infection with Salmonella typhimurium does not result in enhanced intracellular killing.
Langermans JA; van der Hulst ME; Nibbering PH; van Furth R
J Immunol; 1990 Jun; 144(11):4340-6. PubMed ID: 2111344
[TBL] [Abstract][Full Text] [Related]
8. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.
Murray HW; Spitalny GL; Nathan CF
J Immunol; 1985 Mar; 134(3):1619-22. PubMed ID: 3918107
[TBL] [Abstract][Full Text] [Related]
9. Differences in initial rate of intracellular killing of Salmonella typhimurium by resident peritoneal macrophages from various mouse strains.
van Dissel JT; Leijh PC; van Furth R
J Immunol; 1985 May; 134(5):3404-10. PubMed ID: 3920318
[TBL] [Abstract][Full Text] [Related]
10. Microbicidal activities of Salmonella typhimurium- and interferon-gamma-activated mouse peritoneal macrophages.
Langermans JA; Nibbering PH; van der Hulst ME; van Furth R
Pathobiology; 1991; 59(3):189-93. PubMed ID: 1909142
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.
Langermans JA; Van der Hulst ME; Nibbering PH; Hiemstra PS; Fransen L; Van Furth R
J Immunol; 1992 Jan; 148(2):568-74. PubMed ID: 1729374
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
Bermudez LE; Young LS
J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450
[TBL] [Abstract][Full Text] [Related]
13. Differences in the rate of intracellular killing of catalase-negative and catalase-positive Listeria monocytogenes by normal and interferon-gamma-activated macrophages.
van Dissel JT; Stikkelbroeck JJ; van Furth R
Scand J Immunol; 1993 Apr; 37(4):443-6. PubMed ID: 8469926
[TBL] [Abstract][Full Text] [Related]
14. Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice.
Langermans JA; van der Hulst ME; Nibbering PH; van Furth R
Infect Immun; 1992 Dec; 60(12):5107-12. PubMed ID: 1452344
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes.
Murray HW; Scavuzzo D; Jacobs JL; Kaplan MH; Libby DM; Schindler J; Roberts RB
J Immunol; 1987 Apr; 138(8):2457-62. PubMed ID: 3104467
[TBL] [Abstract][Full Text] [Related]
16. Ity influences the production of IFN-gamma by murine splenocytes stimulated in vitro with Salmonella typhimurium.
Ramarathinam L; Niesel DW; Klimpel GR
J Immunol; 1993 May; 150(9):3965-72. PubMed ID: 8473743
[TBL] [Abstract][Full Text] [Related]
17. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
Reed SG
J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
[TBL] [Abstract][Full Text] [Related]
19. Effect of nonspecific stimulation on the defense mechanisms of inbred mice.
Medina S; Vas SI; Robson HG
J Immunol; 1975 Jun; 114(6):1720-5. PubMed ID: 805175
[TBL] [Abstract][Full Text] [Related]
20. Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity.
Kagaya K; Watanabe K; Fukazawa Y
Infect Immun; 1989 Feb; 57(2):609-15. PubMed ID: 2492266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
